OMER
Omeros Corporation
2.57
USD
This page is just a preview of the data found in TrendSpider’s full version
Omeros Corporation stock is up 103.97% since 30 days ago. The next earnings date is Mar 11, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 53.33% of the previous 14 December’s closed higher than November. In the last 5 Unusual Options Trades, there were 5 PUTs. 0% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 16 Oct 13:30 | 20 Oct, 2023 | 3.00 | 2740 | ||
| 16 Oct 14:43 | 20 Oct, 2023 | 3.00 | 2740 | ||
| 16 Oct 14:53 | 19 Jan, 2024 | 5.00 | 1299 | ||
| 30 Nov 14:30 | 19 Jan, 2024 | 5.00 | 1065 | ||
| 30 Nov 14:30 | 19 Jan, 2024 | 8.00 | 111 |
Omeros Corporation discovers, develops, and commercializes small-molecule and protein therapeutics. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA) and atypical hemolytic uremic syndrome (aHUS) The company was incorporated in 1994 and headquartered in Seattle, Washington.
